Learn / PHAT
NASDAQ: PHAT
Phathom Pharmaceuticals (PHAT) stock, explained like you're 5
Phathom Pharmaceuticals trades on the Nasdaq under the ticker PHAT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 587 million dollars.
- Ticker
- PHAT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 587 million dollars
Is Phathom Pharmaceuticals a small, medium or large cap company?
No. Phathom Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 587 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Phathom Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves PHAT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts (Yahoo Finance)
- Phathom Pharmaceuticals (PHAT) Short Interest & Short Float | Updated Oct 2026 $PHAT (MarketBeat)
- Jefferies cuts Phathom Pharmaceuticals price target on 2027 outlook By Investing.com (Investing.com Nigeria)
- Behavioral Patterns of PHAT and Institutional Flows (Stock Traders Daily)
- Phathom Pharmaceuticals (PHAT) Stock Slides Despite Cash Profit Breakthrough (Simply Wall Street)
Follow PHAT in your daily brief
Each trading day at 5 PM ET we post what happened to Phathom Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow PHAT
Questions about Phathom Pharmaceuticals stock
What does Phathom Pharmaceuticals do?
Phathom Pharmaceuticals trades on the Nasdaq under the ticker PHAT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 587 million dollars.
What is the ticker symbol for Phathom Pharmaceuticals?
Phathom Pharmaceuticals trades under the ticker PHAT on the Nasdaq.
What is Phathom Pharmaceuticals's market cap?
Phathom Pharmaceuticals is a small cap stock with a market cap of about 587 million dollars.
How does Phathom Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves PHAT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow PHAT stock every day?
Add PHAT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.